STUDY OF UNKNOWN IMPURITIES IN MEDICINES: AN EXAMPLE OF TIES BETWEEN THE PRODUCTION SECTOR AND ACADEMIA
DOI:
https://doi.org/10.37951/2596-1578.cipeex.2023.12259Keywords:
impurities, stability, identification, characterizationAbstract
The present work addresses the categorization of organic impurities in medications, as well as discusses the identification, isolation, and characterization of unknown degradation products observed during stability and forced degradation studies. The entire approach aims at defining an appropriate specification and analyzing the impurity, enabling a comprehensive understanding of the product, which is an indispensable object during the registration process with the National Health Surveillance Agency (ANVISA). In light of this, this study is the result of technical-scientific cooperation between the productive sector and academia, in the search to identify, isolate, and characterize an unknown impurity found in one of the proton pump inhibitor medications from a pharmaceutical industry.
Downloads
Published
Issue
Section
License
These Proceedings offer free and immediate access to their content, based on the principle that making scientific knowledge freely available to the public fosters the global democratization of knowledge.
Upon publication in the Proceedings, authors retain copyright and publication rights to their articles without restriction.
The Proceedings of the International Congress on Research, Teaching, and Extension (CIPEEX) of the Evangelical University of Goiás (UniEVANGÉLICA) adhere to the terms of the Creative Commons Attribution-NonCommercial 4.0 International license.
